Research Summaries

The FDA has approved oritavancin, an antibacterial drug to treat adults with acute bacterial skin and skin structure infections.

A new study assessed the effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes.

The FDA has approved a new tablet, empagliflozin, to improve glycemic control in adults with type 2 diabetes.

The FDA approved a once-daily, long-term olodaterol inhalation spray to treat patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema with airflow obstruction.

A new study details the effect of smoking on patients with psoriatic arthritis.

Researchers have developed a new, simple, inexpensive test to measure symptoms of pre-dementia.

US teenagers' reported use of synthetic human growth hormone more than doubled between 2012 to 2013 as they sought to improve athletic performance and appearance.

Babies born very early stand a better chance of surviving if they are treated in high-volume neonatal ICUs, a new study shows.

The Society for Healthcare Epidemiology of America offered updated evidence reviews and recommendations for hand hygiene in healthcare facilities.

Researchers studied trends in the incidence of stroke and mortality in adults in the United States over a 24-year period.